Intraosseous Rapid Sequence Intubation

Intraosseous Rapid Sequence IntubationIntravenous (IV) rapid sequence intubation (RSI) is by most considered the gold standard practice for securing an airway in the critically ill. There are, however, scenarios where it may not be possible to get rapid IV access in a timely manner (i.e. severe cutaneous burns, hemorrhagic shock, IV drug users, and/or the morbidly obese). It has been reported that intraosseous (IO) drug administration has similar pharmacokinetics to IV administration, but there have only been a handful of cases reported using the IO route for RSI. In this post we will discuss intraosseous rapid sequence intubation and if it is a feasible practice. (more…)

By |2018-01-30T02:33:28-08:00Jul 7, 2014|Critical Care/ Resus|

Anxiolytics and Hypnotics: Are They Doing Harm?

insomnia clockA patient presents to the emergency department complaining of increasing insomnia due to anxiety. She states that she is not actively suicidal nor homicidal but she has trouble “turning off her brain” at night in order to sleep and her insomnia is worsening her anxiety. She has a history of morbid obesity and smokes 1 pack of cigarettes per day. In order to help you consider writing her a prescription for 5 mg of zolpidem as you presume it to be a benign way to deal with her current sleep disorder. But what does the evidence say about these drugs and the risks of harm? (more…)

By |2016-11-11T19:21:16-08:00Jul 2, 2014|Psychiatry, Tox & Medications|

tPA Administration: Don’t Forget the Leftover Volume in the Pump Tubing

LeftoversWhether alteplase (tPA) is given for ischemic stroke, pulmonary embolism, or STEMI, there is an important practical issue to be aware of during administration. Dr. Charles Bruen (@resusreview) published a great step-by-step pictorial tPA Mixing Tutorial. Once the tPA is mixed, it will invariably be infused via a smart pump through its corresponding tubing. At my institution we use Alaris® CareFusion smart pumps, through the principle applies irrespective of which brand pump is used.

(more…)

PV Card: Local anesthetic toxicity calculations

Local Anesthetic LidocaineLocal anesthetics (LAs) are widely employed to achieve tissue infiltration, peripheral and regional anesthesia, and neuraxial blockades. Despite their well-established toxic dose limits, these agents continue to pose a substantial risk of morbidity and mortality due to local anesthetic toxicity and overdose.

For example, LAs and epinephrine account for a large proportion of medication errors resulting in adverse patient outcomes due to drug dosing miscalculations or errors converting between units. Dosage calculations vary by patient weight as well as by pharmacokinetics and pharmacodynamics of individual LA formulations. Further, non-standard units, additives (epinephrine), and varying concentrations among LAs complicate correct dosage derivations.

Toxicity nomogram

In an effort to curb calculation errors and avert LA toxicity, Williams and Walker derived a helpful nomogram1 to calculate the maximum, weight-based volume of commonly used LAs (lidocaine, prilocaine, bupivacaine, and ropivacaine). This nomogram was validated against a calculator in the original article. Please note that while this nomogram may aid in dosage verification, there is no substitute for a second, independent derivation of the total maximum dose using a different method, as an additional safeguard to prevent dosage error.

Local anesthetic toxicity presentation

LA toxicity presents clinically as a constellation of symptoms including, but not limited to, tinnitus, circumoral tingling, metallic taste, and dizziness. Severe manifestations include altered mentation, arrhythmias, and cardiovascular collapse. Management is predicated upon stopping the offending agent, providing supportive measures, and administering weight-based intravenous 20% lipid emulsion. The authors, Williams and Walker, derived a separate nomogram to guide treatment by calculating the appropriate weight-based lipid therapy, specifying the initial bolus amount, infusion rate, and total maximum dose of lipid emulsion.

Both the toxicity and lipid emulsion nomograms are displayed in this Paucis Verbis card.

Go to ALiEM (PV) Cards for more resources.

Ideal Body Weight (IBW) Calculation

The Devine formulation is the most commonly accepted calculation (most applicable for people at least 60 inches, or 5 feet, tall):

  • IBW for men (kg) = 50 + 2.3 * (Height (in)-60)
  • IBW for women (kg) = 45.5 + 2.3 * (Height (in)-60)

See the MDCalc calculator for IBW.

Reference

  1. Williams D, Walker J. A nomogram for calculating the maximum dose of local anaesthetic. Anaesthesia. 2014;69(8):847-853. [PubMed]

High risk back pain: Cauda Equina Syndrome (EREM)

cauda-equ-disc11Cauda equina syndrome (CES), which occurs due to compression of the distal lumbar and sacral nerve roots, is a potentially devastating cause of back pain. CES is often missed on the patient’s initial visit which can lead to  significant neurologic compromise in a matter of hours [1]. To improve patient outcomes and minimize medicolegal risk, providers need to understand the limitations of the history and physical and carefully consider the diagnosis of CES in any patient with back pain.

(more…)

By |2016-12-20T11:19:57-08:00Jun 9, 2014|Medicolegal, Orthopedic|

Atrial Fibrillation Rate Control in the ED: Calcium Channel Blockers or Beta Blockers?

Screen Shot 2014-05-27 at 2.26.48 AMRate control with IV medications is recommended for atrial fibrillation in the acute setting in patients without preexcitation. This was a Class 1 recommendation (Level of Evidence B) per the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation [1]. What does the evidence say? Are calcium channel blockers or beta blockers better?

(more…)

Go to Top